Intuitive Surgical Beats Q3; Shares Jump on Guidance

Intuitive Surgical beat third-quarter expectations with $2.51 billion in revenue, adjusted EPS of $2.40 and GAAP profit of $704.4 million ($1.95/share). Procedures rose about 20% year-over-year and instruments and accessories sales were $1.52 billion, with more than 80% of those products made at its Mexico facility. The company placed 427 new da Vinci systems in the quarter (including 240 da Vinci 5 units), growing its installed base 13% to 10,763; Ion placements were 50 and Ion procedures rose 52% year-over-year. Intuitive raised its 2025 guidance for worldwide da Vinci-assisted procedure growth to about 17–17.5% (from 15.5–17%) and modestly lifted its adjusted gross profit margin forecast to 67–67.5%, citing a smaller-than-expected tariff impact estimated at about 0.7% of revenue (±10 basis points). Shares jumped roughly 17–18% in after-hours trading following the results and outlook upgrade.